Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Feb. 22, 2024
Abstract
The
COVID-19
pandemic
has
given
rise
to
post-acute
cognitive
symptoms,
often
described
as
‘brain
fog’.
To
comprehensively
grasp
the
extent
of
these
issues,
we
conducted
a
study
integrating
traditional
neuropsychological
assessments
with
experimental
tasks
targeting
attention
control,
working
memory,
and
long-term
three
domains
most
commonly
associated
We
enrolled
33
post-COVID
patients,
all
self-reporting
difficulties,
matched
control
group
(N
=
27)
for
psychological
assessments.
Our
findings
revealed
significant
deficits
in
patients
across
both
measurements
tasks,
evidencing
reduced
performance
involving
interference
resolution
selective
sustained
attention.
Mild
executive
function
naming
impairments
also
emerged
from
assessment.
Notably,
61%
reported
prospective
memory
failures
daily
life,
aligning
our
recruitment
focus.
Furthermore,
patient
showed
alterations
psycho-affective
domain,
indicating
complex
interplay
between
factors,
which
could
point
non-cognitive
determinant
subjectively
experienced
changes
following
COVID-19.
In
summary,
offers
valuable
insights
into
challenges
faced
by
individuals
recovering
COVID-19,
stressing
importance
comprehensive
evaluations
supporting
individuals.
Brain Communications,
Journal Year:
2021,
Volume and Issue:
4(1)
Published: Dec. 15, 2021
The
nature
and
extent
of
persistent
neuropsychiatric
symptoms
after
COVID-19
are
not
established.
To
help
inform
mental
health
service
planning
in
the
pandemic
recovery
phase,
we
systematically
determined
prevalence
survivors
COVID-19.
For
this
pre-registered
systematic
review
meta-analysis
(PROSPERO
ID
CRD42021239750),
searched
MEDLINE,
EMBASE,
CINAHL
PsycINFO
to
20
February
2021,
plus
our
own
curated
database.
We
included
peer-reviewed
studies
reporting
at
post-acute
or
later
time-points
infection
control
groups
where
available.
each
study,
a
minimum
two
authors
extracted
summary
data.
symptom,
calculated
pooled
using
generalized
linear
mixed
models.
Heterogeneity
was
measured
with
I2.
Subgroup
analyses
were
conducted
for
hospitalization,
severity
duration
follow-up.
From
2844
unique
titles,
51
(n
=
18
917
patients).
mean
follow-up
77
days
(range
14-182
days).
Study
quality
most
commonly
moderate.
prevalent
symptom
sleep
disturbance
[pooled
27.4%
(95%
confidence
interval
21.4-34.4%)],
followed
by
fatigue
[24.4%
(17.5-32.9%)],
objective
cognitive
impairment
[20.2%
(10.3-35.7%)],
anxiety
[19.1%
(13.3-26.8%)]
post-traumatic
stress
[15.7%
(9.9-24.1%)].
Only
reported
groups,
both
higher
frequencies
versus
controls.
Between-study
heterogeneity
high
(I2
79.6-98.6%).
There
little
no
evidence
differential
based
on
hospitalization
status,
duration.
Neuropsychiatric
common
from
literature
longer-term
consequences
is
still
maturing
but
indicates
particularly
insomnia,
fatigue,
disorders
first
6
months
infection.
Brain and Behavior,
Journal Year:
2022,
Volume and Issue:
12(3)
Published: Feb. 8, 2022
While
much
of
the
scientific
focus
thus
far
has
been
on
cognitive
sequelae
in
patients
with
severe
COVID-19,
subjective
complaints
are
being
reported
across
spectrum
disease
severity,
recent
studies
beginning
to
corroborate
patients'
perceived
deficits.
In
response
this,
aims
this
study
were
(1)
explore
frequency
impaired
performance
domains
post-COVID
and
(2)
uncover
whether
impairment
existed
within
a
single
domain
or
multiple.Sixty-three
assessed
comprehensive
protocol
consisting
various
neuropsychological
tests
mood
measures.
Cognitive
test
was
transformed
into
T
scores
classified
based
recommended
guidelines.
After
performing
principal
component
analysis
define
factors,
distributions
analyzed.Results
revealed
pervasive
impact
attention
abilities,
both
as
singularly
affected
(19%
single-domain
impairment)
well
coupled
decreased
executive
functions,
learning,
long-term
memory.
These
salient
attentional
associated
deficits
largely
unrelated
clinical
factors
such
hospitalization,
duration,
biomarkers,
affective
measures.These
findings
stress
importance
evaluation
intervention
address
varying
courses,
not
just
those
who
hospitalized
experienced
symptoms.
Future
should
investigate
what
extent
these
abilities
recuperated
over
time
employ
neuroimaging
techniques
underlying
mechanisms
neural
damage.
Brain Communications,
Journal Year:
2021,
Volume and Issue:
4(1)
Published: Dec. 15, 2021
Abstract
Recent
studies
indicate
that
COVID-19
infection
can
lead
to
serious
neurological
consequences
in
a
small
percentage
of
individuals.
However,
the
months
following
acute
illness,
many
more
suffer
from
fatigue,
low
motivation,
disturbed
mood,
poor
sleep
and
cognitive
symptoms,
colloquially
referred
as
‘brain
fog’.
But
what
about
individuals
who
had
asymptomatic
moderate
reported
no
concerns
after
recovering
COVID-19?
Here,
we
examined
wide
range
functions
critical
for
daily
life
(including
sustained
attention,
memory,
motor
control,
planning,
semantic
reasoning,
mental
rotation
spatial–visual
attention)
people
previously
suffered
but
were
not
significantly
different
control
group
on
self-reported
forgetfulness,
abnormality,
depression,
anxiety
personality
profile.
Reassuringly,
survivors
performed
well
most
abilities
tested,
including
working
executive
function,
planning
rotation.
they
displayed
worse
episodic
memory
(up
6
post-infection)
greater
decline
vigilance
with
time
task
(for
up
9
months).
Overall,
results
show
specific
chronic
changes
are
evident
objective
testing
even
amongst
those
do
report
symptom
burden.
Importantly,
sample
tested
here,
these
normal
6–9
months,
demonstrating
evidence
recovery
over
time.
BMJ Open,
Journal Year:
2022,
Volume and Issue:
12(2), P. e056366 - e056366
Published: Feb. 1, 2022
To
explore
the
lived
experience
of
'brain
fog'-the
wide
variety
neurocognitive
symptoms
that
can
follow
COVID-19.A
UK-wide
longitudinal
qualitative
study
comprising
online
focus
groups
with
email
follow-up.50
participants
were
recruited
from
a
previous
long
COVID-19
(n=23)
and
support
for
people
persistent
following
(n=27).
In
remotely
held
groups,
invited
to
describe
their
comment
on
others'
accounts.
Individuals
followed
up
by
4-6
months
later.
Data
audiotaped,
transcribed,
anonymised
coded
in
NVIVO.
They
analysed
an
interdisciplinary
team
expertise
general
practice,
clinical
neuroscience,
sociology
chronic
illness
service
delivery,
checked
brain
fog.Of
50
participants,
42
female
32
white
British.
Most
had
never
been
hospitalised
COVID-19.
Qualitative
analysis
revealed
themes:
mixed
views
appropriateness
term
fog';
rich
descriptions
(especially
executive
function,
attention,
memory
language),
accounts
how
fluctuated-and
progressed
over
time;
profound
psychosocial
impact
condition
relationships,
personal
professional
identity;
self-perceptions
guilt,
shame
stigma;
strategies
used
self-management;
challenges
accessing
navigating
healthcare
system;
participants'
search
physical
mechanisms
explain
symptoms.These
findings
complement
research
into
epidemiology
after
Services
such
patients
should
include:
ongoing
therapeutic
relationship
clinician
who
engages
its
personal,
social
occupational
context
as
well
specialist
services
include
provision
symptoms,
are
accessible,
easily
navigable,
comprehensive
interdisciplinary.
European Journal of Neurology,
Journal Year:
2022,
Volume and Issue:
29(7), P. 2006 - 2014
Published: March 14, 2022
Cognitive
dysfunction
has
been
observed
following
recovery
from
COVID-19.
To
the
best
of
our
knowledge,
however,
no
study
assessed
progression
cognitive
impairment
after
1
year.
The
aim
was
to
assess
functioning
at
year
hospital
discharge,
and
eventual
associations
with
specific
clinical
variables.Seventy-six
patients
(aged
22-74
years)
who
had
hospitalized
for
COVID-19
were
recruited.
Patients
received
neuropsychological
assessments
5
(n
=
76)
12
months
53)
discharge.Over
half
(63.2%)
deficits
in
least
one
test
months.
Compared
assessment
months,
verbal
memory,
attention
processing
speed
improved
significantly
(all
p
<
0.05),
whereas
visuospatial
memory
did
not
>
0.500).
most
affected
domains
(28.3%)
long-term
(18.1%)
(15.1%)
memory.
Lower
PaO2
/FiO2
ratios
acute
phase
associated
worse
(p
0.029)
learning
0.041)
Worse
hyposmia
0.020)
dysgeusia
0.037).Our
expands
results
previous
studies
showing
that
can
still
be
severe
should
receive
periodic
follow-up
evaluations,
as
recovered
could
have
social
occupational
implications.
Frontiers in Psychology,
Journal Year:
2022,
Volume and Issue:
13
Published: Feb. 17, 2022
Previous
studies
of
post-acute
COVID-19
syndrome
have
focused
on
critical
cases
with
severe
disease.
However,
most
are
mild
to
moderate
in
disease
severity.
EClinicalMedicine,
Journal Year:
2024,
Volume and Issue:
68, P. 102434 - 102434
Published: Jan. 25, 2024
Summary
Background
COVID-19
survivors
may
experience
a
wide
range
of
chronic
cognitive
symptoms
for
months
or
years
as
part
post-COVID-19
conditions
(PCC).
To
date,
there
is
no
definitive
objective
marker
PCC.
We
hypothesised
that
key
common
deficit
in
people
with
PCC
might
be
generalised
slowing.
Methods
examine
slowing,
patients
completed
two
short
web-based
tasks,
Simple
Reaction
Time
(SRT)
and
Number
Vigilance
Test
(NVT).
270
diagnosed
at
different
clinics
UK
Germany
were
compared
to
control
groups:
individuals
who
contracted
before
but
did
not
after
recovery
(No-PCC
group)
uninfected
(No-COVID
group).
All
the
study
between
May
18,
2021
July
4,
2023
Jena
University
Hospital,
Jena,
Long
COVID
clinic,
Oxford,
UK.
Findings
identified
pronounced
slowing
PCC,
which
distinguished
them
from
age-matched
healthy
previously
had
symptomatic
manifest
Cognitive
was
evident
even
on
30-s
task
measuring
simple
reaction
time
(SRT),
responding
stimuli
∼3
standard
deviations
slower
than
controls.
53.5%
PCC's
response
speed
2
mean,
indicating
high
prevalence
This
finding
replicated
across
clinic
samples
Comorbidities
such
fatigue,
depression,
anxiety,
sleep
disturbance,
post-traumatic
stress
disorder
account
extent
Furthermore,
SRT
highly
correlated
poor
performance
NVT
measure
sustained
attention.
Interpretation
Together,
these
results
robustly
demonstrate
distinguishes
an
important
factor
contributing
some
impairments
reported
Funding
Wellcome
Trust
(206330/Z/17/Z),
NIHR
Oxford
Health
Biomedical
Research
Centre,
Thüringer
Aufbaubank
(2021
FGI
0060),
German
Forschungsgemeinschaft
(DFG,
FI
1424/2-1)
Horizon
2020
Framework
Programme
European
Union
(ITN
SmartAge,
H2020-MSCA-ITN-2019-859890).
BMJ Open,
Journal Year:
2021,
Volume and Issue:
11(10), P. e055164 - e055164
Published: Oct. 1, 2021
Objectives
To
report
findings
on
brain
MRI
and
neurocognitive
function,
as
well
persisting
fatigue
at
long-term
follow-up
after
COVID-19
hospitalisation
in
patients
identified
high
risk
for
affection
of
the
central
nervous
system.
Design
Ambidirectional
observational
cohort
study.
Setting
All
734
from
a
regional
population
Sweden
with
laboratory-confirmed
diagnosis
admitted
to
hospital
during
period
1
March
31
May
2020.
Participants
A
subgroup
(n=185)
symptoms
still
interfering
daily
life
telephone
4
months
discharge
were
invited
medical
neuropsychological
evaluation.
Thirty-five
those
who
assessed
test
battery
clinical
visit,
presented
picture
concerning
COVID-19-related
pathology,
further
investigated
by
MRI.
Main
outcome
measures
Findings
MRI,
results
reported
fatigue.
Results
Twenty-five
(71%)
had
abnormalities
MRI;
multiple
white
matter
lesions
most
common
finding.
Sixteen
(46%)
demonstrated
impaired
which
10
(29%)
severe
impairment.
Twenty-six
(74%)
clinically
significant
Patients
lower
Visuospatial
Index
(p=0.031)
compared
group
normal
findings.
Conclusions
In
this
selected
undergo
evaluation,
majority
abnormal
and/or
results.
Abnormal
not
restricted
disease.